28-Aug-2026
Oscar Health Sees Record Profitability in 2026 First Half—Membership Grows by 46% and Outlook Raised
Market Chameleon (Thu, 6-Aug 3:09 AM ET)
Business Wire (Thu, 6-Aug 6:00 AM ET)
Oscar Health, Inc. to Host 2026 Investor Day
Business Wire (Tue, 28-Jul 8:00 AM ET)
Oscar Health, Inc. 2026 Second Quarter Earnings Conference Call
Business Wire (Mon, 13-Jul 8:00 AM ET)
Market Chameleon (Tue, 21-Apr 3:09 AM ET)
Oscar Health Gains Experienced Board Leadership with Bill Gassen’s Appointment
Market Chameleon (Mon, 30-Mar 4:56 AM ET)
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
Oscar Health Class A trades on the NYSE stock market under the symbol OSCR.
As of August 28, 2026, OSCR stock price climbed to $30.47 with 4,688,170 million shares trading.
OSCR has a beta of 2.30, meaning it tends to be more sensitive to market movements. OSCR has a correlation of 0.15 to the broad based SPY ETF.
OSCR has a market cap of $9.40 billion. This is considered a Mid Cap stock.
Last quarter Oscar Health Class A reported $5 billion in Revenue and $1.10 earnings per share. This beat revenue expectation by $122 million and exceeded earnings estimates by $.78.
In the last 3 years, OSCR traded as high as $33.55 and as low as $4.72.
The top ETF exchange traded funds that OSCR belongs to (by Net Assets): VTI, AVUV, IWM, VB, VBK.
OSCR has outperformed the market in the last year with a return of +76.7%, while the SPY ETF gained +19.7%. In the last 3 month period, OSCR beat the market returning +36.5%, while SPY returned +2.2%. However, in the most recent 2 weeks OSCR has underperformed the stock market by returning -7.0%, while SPY returned -0.9%.
OSCR support price is $28.72 and resistance is $31.38 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OSCR shares will trade within this expected range on the day.